1830P CBP-1018, a bi-ligand-drug conjugate treated in patients with advanced solid tumors: A phase I, multi-center, open-label, dose-escalation and dose expansion study

K. Li,J. Wu,S. Ye,Y. liu, H. Huang, F. fan,Y. lai, S. Zhuang, L. Zhou, R. Huang, Y. Teng, X. Chai, J. Zhang, Y. Shi,H. Huang

Annals of Oncology(2023)

引用 0|浏览2
暂无评分
关键词
advanced solid tumors,bi-ligand-drug,multi-center,open-label,dose-escalation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要